Diastolic Dysfunction
86
5
8
43
Key Insights
Highlights
Success Rate
84% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.3%
8 terminated out of 86 trials
84.3%
-2.3% vs benchmark
16%
14 trials in Phase 3/4
16%
7 of 43 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 43 completed trials
Clinical Trials (86)
Diastolic Dysfunction and Inflammatory Biomarkers in Lupus Nephritis
The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
Exploratory Study of the Diagnostic Potential of an Innovative Thoracic Vibration Analysis Technique
Polyamine Treatment in Elderly Patients With Coronary Artery Disease
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
Changes in Intramyocardial Fat Assessed by Cardiac CT Before and After Bariatric Surgery and Their Relationship With Cardiac Diastolic Function
Effect of Intradialytic Exercise on Left Ventricular Diastolic Function in Hemodialysis Patients
Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension
Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock
Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography
AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction
A Cross-sectional Study on the Impact of Shift Work on Diastolic Dysfunction in Healthcare Workers
PDD in Type 2 Diabetes w/wo Diastolic Dysfunction
Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.
Effect of Swimming Exercise on Diastolic Dysfunction
Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function
MitoQ Supplementation and Cardiovascular Function in Healthy Men and Women
Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors
Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI
Diastolic Dysfunction PPCM in Patients With Documented Left Ventricular Systolic Function Recovery